Is There a Role for Using NMR Urine Metabolomics as a New Method of Screening for Colorectal Cancer?
Inclusion Criteria:
For Screening group (normal colonoscopy & colonic polyps):
- asymptomatic, 50-75 year old, without personal or family history of CRC/polyps
- asymptomatic, 40-75 year old, known personal or first-degree family history of
either CRC or polyps
For Cancer group:
- any patient with diagnosis of colorectal cancer
- any patient with diagnosis of prostate cancer
- any patient with diagnosis of breast cancer
Exclusion Criteria:
For screening group:
- hematochezia
- inflammatory bowel disease
- on anticoagulation for reasons other than atrial fibrillation
- significant co-morbidities
For Cancer group:
- already had neoadjuvant treatment at time of urine collection
- no invasive cancer at time of urine collection